Levels of fibrin/fibrinogen degradation products have been measured by a sensitive and specific radioimmunoassay in pregnancies associated with pre-eclampsia or essential hypertension. The incidence of elevated levels was low (2-4%) in mild and moderate cases, and rather higher (30%) in severe cases. In no patients were the levels consistently elevated prior to the onset of clinical signs.
No takes yet. Share an insight, caveat, or question.
Gordon et al. (1976) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: